ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
27.85
-0.37 (-1.31%)
Jul 21, 2026, 3:47 PM EDT - Market open
ArriVent BioPharma Market Cap
ArriVent BioPharma has a market cap or net worth of $1.3 billion as of July 21, 2026. Its market cap has increased by 62.17% in one year.
Market Cap
1.30B
Enterprise Value
985.12M
1-Year Change
62.17%
Ranking
Category
Stock Price
$27.85
ChartMarket Cap Chart
Since the IPO on January 26, 2024, ArriVent BioPharma's market cap has increased from $575.22M to $1.30B, an increase of 125.50%. That is a compound annual growth rate of 38.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 1.55B | 86.11% |
| Dec 31, 2025 | 830.58M | -7.48% |
| Dec 31, 2024 | 897.69M | 56.06% |
| Jan 26, 2024 | 575.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xencor | 1.39B |
| Savara | 1.39B |
| Absci | 1.38B |
| Aktis Oncology | 1.32B |
| Novavax | 1.30B |
| First Tracks Biotherapeutics | 1.29B |
| Avalyn Pharma | 1.27B |
| Immatics | 1.26B |